{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:53:39Z","timestamp":1740138819473,"version":"3.37.3"},"reference-count":53,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2017,3,16]],"date-time":"2017-03-16T00:00:00Z","timestamp":1489622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"},{"start":{"date-parts":[[2017,3,16]],"date-time":"2017-03-16T00:00:00Z","timestamp":1489622400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions"}],"funder":[{"name":"Australian Postgraduate Award"},{"name":"University of Sydney Postgraduate Award"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Proteins"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1002\/prot.25235","type":"journal-article","created":{"date-parts":[[2017,1,5]],"date-time":"2017-01-05T23:16:47Z","timestamp":1483658207000},"page":"827-842","source":"Crossref","is-referenced-by-count":4,"title":["Molecular dynamics simulations reveal structural insights into inhibitor binding modes and functionality in human Group IIA phospholipase A<sub>2<\/sub>"],"prefix":"10.1002","volume":"85","author":[{"given":"Ryung Rae","family":"Kim","sequence":"first","affiliation":[{"name":"Group in Biomolecular Structure and Informatics, Faculty of Pharmacy; The University of Sydney; Sydney NSW 2006 Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alpeshkumar K.","family":"Malde","sequence":"additional","affiliation":[{"name":"School of Chemistry and Molecular Biosciences; University of Queensland; Brisbane QLD Australia 4072"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"Nematollahi","sequence":"additional","affiliation":[{"name":"Group in Biomolecular Structure and Informatics, Faculty of Pharmacy; The University of Sydney; Sydney NSW 2006 Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kieran F.","family":"Scott","sequence":"additional","affiliation":[{"name":"School of Medicine; Western Sydney University, The Ingham Institute for Applied Medical Research; Liverpool NSW Australia 2170"},{"name":"Centre for Oncology Education and Research Translation (CONCERT), The Ingham Institute for Applied Medical Research; Liverpool NSW Australia 2170"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8033-5518","authenticated-orcid":false,"given":"W. Bret","family":"Church","sequence":"additional","affiliation":[{"name":"Group in Biomolecular Structure and Informatics, Faculty of Pharmacy; The University of Sydney; Sydney NSW 2006 Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,3,16]]},"reference":[{"key":"10.1002\/prot.25235-BIB0001|prot25235-cit-0001","doi-asserted-by":"crossref","first-page":"6130","DOI":"10.1021\/cr200085w","article-title":"Phospholipase A2 Enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention","volume":"111","author":"Dennis","year":"2011","journal-title":"Chem Rev"},{"key":"10.1002\/prot.25235-BIB0002|prot25235-cit-0002","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/0076-6879(91)97138-O","article-title":"Phospholipase A2-catalyzed hydrolysis of vesicles: uses of interfacial catalysis in the scooting mode","volume":"197","author":"Jain","year":"1991","journal-title":"Methods Enzymol"},{"key":"10.1002\/prot.25235-BIB0003|prot25235-cit-0003","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.bbalip.2006.08.002","article-title":"The interfacial binding surface of phospholipase A2s","volume":"1761","author":"Winget","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"10.1002\/prot.25235-BIB0004|prot25235-cit-0004","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S0006-291X(88)80275-4","article-title":"Phospholipase A2 from human synovial fluid: purification and structural homology to the placental enzyme","volume":"157","author":"Lai","year":"1988","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1002\/prot.25235-BIB0005|prot25235-cit-0005","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/oxfordjournals.jbchem.a122467","article-title":"Amino acid composition and NH2-terminal amino acid sequence of human phospholipase A2 purified from rheumatoid synovial fluid","volume":"104","author":"Hara","year":"1988","journal-title":"J Biochem"},{"key":"10.1002\/prot.25235-BIB0006|prot25235-cit-0006","doi-asserted-by":"crossref","first-page":"5335","DOI":"10.1016\/S0021-9258(18)83549-9","article-title":"Cloning and recombinant expression of phospholipase A2 present in rheumatoid arthritic synovial fluid","volume":"264","author":"Seilhamer","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1002\/prot.25235-BIB0007|prot25235-cit-0007","doi-asserted-by":"crossref","first-page":"5768","DOI":"10.1016\/S0021-9258(18)83616-X","article-title":"Structure and properties of a human non-pancreatic phospholipase A2","volume":"264","author":"Kramer","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1002\/prot.25235-BIB0008|prot25235-cit-0008","first-page":"1351","article-title":"Serum phospholipase-A2 correlates with disease-activity in rheumatoid-arthritis","volume":"15","author":"Pruzanski","year":"1988","journal-title":"J Rheumatol"},{"key":"10.1002\/prot.25235-BIB0009|prot25235-cit-0009","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ijcard.2005.04.004","article-title":"CRP, interleukin-6, secretory phospholipase A2 group IIA, and intercellular adhesion molecule-1 during the early phase of acute coronary syndromes and long-term follow-up","volume":"108","author":"Hartford","year":"2006","journal-title":"Int J Cardiol"},{"key":"10.1002\/prot.25235-BIB0010|prot25235-cit-0010","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0008-6363(03)00324-9","article-title":"Type II secretory phospholipase A2 in cardiovascular disease: a mediator in atherosclerosis and ischemic damage to cardiomyocytes?","volume":"60","author":"Niessen","year":"2003","journal-title":"Cardiovasc Res"},{"key":"10.1002\/prot.25235-BIB0011|prot25235-cit-0011","first-page":"413","article-title":"Plasma levels of type II phospholipase A2 and cytokines in patients with sepsis","volume":"90","author":"Endo","year":"1995","journal-title":"Res Commun Mol Pathol Pharmacol"},{"key":"10.1002\/prot.25235-BIB0012|prot25235-cit-0012","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s12253-013-9652-y","article-title":"Plasma levels of phospholipase A2-IIA in patients with different types of malignancies: prognosis and association with inflammatory and coagulation biomarkers","volume":"19","author":"Menschikowski","year":"2013","journal-title":"Pathol Oncol Res"},{"key":"10.1002\/prot.25235-BIB0013|prot25235-cit-0013","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.biochi.2010.03.019","article-title":"Emerging roles for phospholipase A2 enzymes in cancer","volume":"92","author":"Scott","year":"2010","journal-title":"Biochimie"},{"key":"10.1002\/prot.25235-BIB0014|prot25235-cit-0014","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1080\/00365520152584879","article-title":"Expression of group II phospholipase A2 in the liver in acute pancreatitis","volume":"36","author":"Talvinen","year":"2001","journal-title":"Scand J Gastroenterol"},{"key":"10.1002\/prot.25235-BIB0015|prot25235-cit-0015","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1164\/ajrccm.155.2.9032172","article-title":"Phospholipase A2 and arachidonate increase in bronchoalveolar lavage fluid after inhaled antigen challenge in asthmatics","volume":"155","author":"Bowton","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1002\/prot.25235-BIB0016|prot25235-cit-0016","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/rheumatology\/31.3.175","article-title":"Measurement of human phospholipase A2 in arthritis plasma using a newly developed sandwich ELISA","volume":"31","author":"Smith","year":"1992","journal-title":"Br J Rheumatol"},{"key":"10.1002\/prot.25235-BIB0017|prot25235-cit-0017","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1472-6807-7-82","article-title":"Characterization of a human coagulation factor Xa-binding site on Viperidae snake venom phospholipases A2 by affinity binding studies and molecular bioinformatics","volume":"7","author":"Faure","year":"2007","journal-title":"BMC Struct Biol"},{"key":"10.1002\/prot.25235-BIB0018|prot25235-cit-0018","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.toxicon.2003.11.002","article-title":"Excitement ahead: structure, function and mechanism of snake venom phospholipase A2 enzymes","volume":"42","author":"Kini","year":"2003","journal-title":"Toxicon"},{"key":"10.1002\/prot.25235-BIB0019|prot25235-cit-0019","doi-asserted-by":"crossref","first-page":"48523","DOI":"10.1074\/jbc.M203137200","article-title":"On the binding preference of human groups IIA and X phospholipases A2 for membranes with anionic phospholipids","volume":"277","author":"Bezzine","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1002\/prot.25235-BIB0020|prot25235-cit-0020","doi-asserted-by":"crossref","first-page":"11881","DOI":"10.1074\/jbc.274.17.11881","article-title":"Roles of Trp31 in high membrane binding and proinflammatory activity of human group V phospholipase A2","volume":"274","author":"Han","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1002\/prot.25235-BIB0021|prot25235-cit-0021","doi-asserted-by":"crossref","first-page":"48535","DOI":"10.1074\/jbc.M205855200","article-title":"Interfacial kinetic and binding properties of the complete set of human and mouse groups I, II, V, X, and XII secreted phospholipases A2","volume":"277","author":"Singer","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1002\/prot.25235-BIB0022|prot25235-cit-0022","doi-asserted-by":"crossref","first-page":"13203","DOI":"10.1021\/bi981223t","article-title":"Tryptophan-containing mutant of human (group IIa) secreted phospholipase A(2) has a dramatically increased ability to hydrolyze phosphatidylcholine vesicles and cell membranes","volume":"37","author":"Baker","year":"1998","journal-title":"Biochemistry"},{"key":"10.1002\/prot.25235-BIB0023|prot25235-cit-0023","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1074\/jbc.M110.123927","article-title":"A bifunctional role for group IIA secreted phospholipase A2 in human rheumatoid fibroblast-like synoviocyte arachidonic acid metabolism","volume":"286","author":"Bryant","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1002\/prot.25235-BIB0024|prot25235-cit-0024","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0006-291X(02)02920-0","article-title":"Secreted phospholipases A2 induce the expression of chemokines in microvascular endothelium","volume":"300","author":"Beck","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1002\/prot.25235-BIB0025|prot25235-cit-0025","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1161\/01.ATV.0000164310.67356.a9","article-title":"Autocrine and paracrine transcriptional regulation of type IIA secretory phospholipase A2 gene in vascular smooth muscle cells","volume":"25","author":"Jaulmes","year":"2005","journal-title":"Arterioscl Thromb Vasc Biol"},{"key":"10.1002\/prot.25235-BIB0026|prot25235-cit-0026","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1096\/fj.02-0938com","article-title":"Interaction of low molecular weight group IIA phospholipase A2 with apoptotic human T cells: role of heparan sulfate proteoglycans","volume":"17","author":"Boilard","year":"2003","journal-title":"FASEB J"},{"key":"10.1002\/prot.25235-BIB0027|prot25235-cit-0027","doi-asserted-by":"crossref","first-page":"26107","DOI":"10.1074\/jbc.M804835200","article-title":"Pro-inflammatory secretory phospholipase a2 type IIA binds to integrins alpha v beta 3 and alpha 4 beta 1 and induces proliferation of monocytic cells in an integrin-dependent manner","volume":"283","author":"Saegusa","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1002\/prot.25235-BIB0028|prot25235-cit-0028","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1074\/jbc.M114.579946","article-title":"Proinflammatory secreted phospholipase A2 type IIA (sPLA-IIA) induces integrin activation through direct binding to a newly identified binding site (site 2) in integrins alphavbeta3, alpha4beta1, and alpha5beta1","volume":"290","author":"Fujita","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1002\/prot.25235-BIB0029|prot25235-cit-0029","doi-asserted-by":"crossref","first-page":"15269","DOI":"10.1074\/jbc.M112.397893","article-title":"Selective inhibition of human group IIA-secreted phospholipase A2 (hGIIA) signaling reveals arachidonic acid metabolism is associated with colocalization of hGIIA to vimentin in rheumatoid synoviocytes","volume":"288","author":"Lee","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1002\/prot.25235-BIB0030|prot25235-cit-0030","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/jmr.960","article-title":"Simultaneous inhibition of anti-coagulation and inflammation: crystal structure of phospholipase A2 complexed with indomethacin at 1.4 A resolution reveals the presence of the new common ligand-binding site","volume":"22","author":"Singh","year":"2009","journal-title":"J Mol Recognit"},{"key":"10.1002\/prot.25235-BIB0031|prot25235-cit-0031","doi-asserted-by":"crossref","first-page":"23992","DOI":"10.1074\/jbc.271.39.23992","article-title":"Native peptide inhibition. Specific inhibition of type II phospholipases A2 by synthetic peptides derived from the primary sequence","volume":"271","author":"Tseng","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1002\/prot.25235-BIB0032|prot25235-cit-0032","doi-asserted-by":"crossref","first-page":"33156","DOI":"10.1074\/jbc.M101272200","article-title":"A novel approach to the design of inhibitors of human secreted phospholipase A2 based on native peptide inhibition","volume":"276","author":"Church","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1002\/prot.25235-BIB0033|prot25235-cit-0033","doi-asserted-by":"crossref","first-page":"41079","DOI":"10.1074\/jbc.M206130200","article-title":"Crystal structure of a complex formed between a snake venom phospholipase A2 and a potent peptide inhibitor Phe-Leu-Ser-Tyr-Lys at 1.8 A resolution","volume":"277","author":"Chandra","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1002\/prot.25235-BIB0034|prot25235-cit-0034","doi-asserted-by":"crossref","unstructured":"Kumar M Kumar S Vikram G Singh N Sinha M Bhushan A Kaur P Srinivasan A Sharma S Singh TP. Crystal structure determination of a ternary complex of phospholipase A2 with a pentapeptide FLSYK and Ajmaline at 2.5 A resolution. Protein Databank 2008","DOI":"10.2210\/pdb3cbi\/pdb"},{"key":"10.1002\/prot.25235-BIB0035|prot25235-cit-0035","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/cbic.200390029","article-title":"D-Tyrosine as a chiral precusor to potent inhibitors of human nonpancreatic secretory phospholipase A2 (IIa) with antiinflammatory activity","volume":"4","author":"Hansford","year":"2003","journal-title":"ChemBioChem"},{"key":"10.1002\/prot.25235-BIB0036|prot25235-cit-0036","doi-asserted-by":"crossref","first-page":"4026","DOI":"10.1021\/ct200196m","article-title":"An automated force field topology builder (ATB) and repository: Version 1.0","volume":"7","author":"Malde","year":"2011","journal-title":"J Chem Theory Comput"},{"key":"10.1002\/prot.25235-BIB0037|prot25235-cit-0037","first-page":"331342","volume-title":"Intermolecular forces: Proceedings of the Fourteenth Jerusalem Symposium on Quantum Chemistry and Biochemistry Held in Jerusalem, Israel, April 13-16, 1981","author":"Berendsen","year":"1981"},{"key":"10.1002\/prot.25235-BIB0038|prot25235-cit-0038","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1107\/S0907444910045749","article-title":"Overview of the CCP4 suite and current developments","volume":"67","author":"Winn","year":"2011","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1002\/prot.25235-BIB0039|prot25235-cit-0039","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.cpc.2011.12.014","article-title":"Architecture, implementation and parallelisation of the GROMOS software for biomolecular simulation","volume":"183","author":"Schmid","year":"2012","journal-title":"Comput Phys Commun"},{"key":"10.1002\/prot.25235-BIB0040|prot25235-cit-0040","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1021\/ct2003622","article-title":"GROMOS++ software for the analysis of biomolecular simulation trajectories","volume":"7","author":"Eichenberger","year":"2011","journal-title":"J Chem Theory Comput"},{"key":"10.1002\/prot.25235-BIB0041|prot25235-cit-0041","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s00249-011-0700-9","article-title":"Definition and testing of the GROMOS force-field versions 54A7 and 54B7","volume":"40","author":"Schmid","year":"2011","journal-title":"Eur Biophys J"},{"key":"10.1002\/prot.25235-BIB0042|prot25235-cit-0042","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1063\/1.448118","article-title":"Molecular dynamics with coupling to an external bath","volume":"81","author":"Berendsen","year":"1984","journal-title":"J Chem Phys"},{"key":"10.1002\/prot.25235-BIB0043|prot25235-cit-0043","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0021-9991(77)90098-5","article-title":"Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes","volume":"23","author":"Ryckaert","year":"1977","journal-title":"J Comput Phys"},{"key":"10.1002\/prot.25235-BIB0044|prot25235-cit-0044","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.jmb.2007.05.022","article-title":"Inference of macromolecular assemblies from crystalline state","volume":"372","author":"Krissinel","year":"2007","journal-title":"J Mol Biol"},{"key":"10.1002\/prot.25235-BIB0045|prot25235-cit-0045","doi-asserted-by":"crossref","first-page":"W375","DOI":"10.1093\/nar\/gkm216","article-title":"MolProbity: all-atom contacts and structure validation for proteins and nucleic acids","volume":"35","author":"Davis","year":"2007","journal-title":"Nucleic Acids Res"},{"key":"10.1002\/prot.25235-BIB0046|prot25235-cit-0046","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10822-010-9397-6","article-title":"Challenges in the determination of the binding modes of non-standard ligands in X-ray crystal complexes","volume":"25","author":"Malde","year":"2011","journal-title":"J Comput Aided Mol Des"},{"key":"10.1002\/prot.25235-BIB0047|prot25235-cit-0047","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.drudis.2008.06.006","article-title":"Limitations and lessons in the use of X-ray structural information in drug design","volume":"13","author":"Davis","year":"2008","journal-title":"Drug Discov Today"},{"key":"10.1002\/prot.25235-BIB0048|prot25235-cit-0048","doi-asserted-by":"crossref","first-page":"3848","DOI":"10.1021\/ja9002124","article-title":"Binding and enantiomeric selectivity of threonyl-tRNA synthetase","volume":"131","author":"Malde","year":"2009","journal-title":"J Am Chem Soc"},{"key":"10.1002\/prot.25235-BIB0049|prot25235-cit-0049","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s10822-015-9833-8","article-title":"Models of protein-ligand crystal structures: trust, but verify","volume":"29","author":"Deller","year":"2015","journal-title":"J Comput Aided Mol Des"},{"key":"10.1002\/prot.25235-BIB0050|prot25235-cit-0050","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1517\/17460441.2014.872623","article-title":"The future of crystallography in drug discovery","volume":"9","author":"Zheng","year":"2014","journal-title":"Expert Opin Drug Discov"},{"key":"10.1002\/prot.25235-BIB0051|prot25235-cit-0051","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.drudis.2012.06.011","article-title":"Essential considerations for using protein-ligand structures in drug discovery","volume":"17","author":"Warren","year":"2012","journal-title":"Drug Discov Today"},{"key":"10.1002\/prot.25235-BIB0052|prot25235-cit-0052","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10822-011-9538-6","article-title":"The good, the bad and the twisted: a survey of ligand geometry in protein crystal structures","volume":"26","author":"Liebeschuetz","year":"2012","journal-title":"J Comput Aided Mol Des"},{"key":"10.1002\/prot.25235-BIB0053|prot25235-cit-0053","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1002\/pro.2923","article-title":"The impact of crystallization conditions on structure-based drug design: a case study on the methylene blue\/acetylcholinesterase complex","volume":"25","author":"Dym","year":"2016","journal-title":"Protein Sci"}],"container-title":["Proteins: Structure, Function, and Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fprot.25235","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/prot.25235","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T20:35:13Z","timestamp":1658349313000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/prot.25235"}},"subtitle":["MD Simulations of Group IIA Phospholipases A2"],"short-title":[],"issued":{"date-parts":[[2017,3,16]]},"references-count":53,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"URL":"https:\/\/doi.org\/10.1002\/prot.25235","archive":["Portico"],"relation":{},"ISSN":["0887-3585"],"issn-type":[{"type":"print","value":"0887-3585"}],"subject":[],"published":{"date-parts":[[2017,3,16]]}}}